Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study

scientific article published on 01 August 2014

Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4244/EIJY14M06_01
P698PubMed publication ID24929350

P50authorMauricio G. CohenQ39066286
Jarosław KasprzakQ68692773
Jan H CornelQ91960546
Ian J. SarembockQ106705959
John H. AlexanderQ110877755
P2093author name stringRoxana Mehran
Richard C Becker
Christopher E Buller
Gilles Montalescot
Thomas J Povsic
John P Vavalle
Peter S Fail
Steven L Zelenkofske
Laura H Aberle
RADAR Investigators
P433issue4
P921main subjectanticoagulationQ63279445
P304page(s)431-438
P577publication date2014-08-01
P1433published inEuroInterventionQ26842537
P1476titleUse of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study
P478volume10

Reverse relations

cites work (P2860)
Q38290290Aptamers as targeted therapeutics: current potential and challenges
Q41901691High-affinity RNA Aptamers Against the HIV-1 Protease Inhibit Both In Vitro Protease Activity and Late Events of Viral Replication
Q57174720RNA Therapeutics in Cardiovascular Precision Medicine
Q36580126Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant
Q89217812Venous thrombosis

Search more.